Crossmark

Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course

Crossref DOI link: https://doi.org/10.1007/s00415-018-8994-5

Published Online: 2018-08-28

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stampanoni Bassi, Mario https://orcid.org/0000-0003-4664-850X
Iezzi, Ennio https://orcid.org/0000-0001-8213-0535
Landi, Doriana

Monteleone, Fabrizia

Gilio, Luana https://orcid.org/0000-0001-7132-9098
Simonelli, Ilaria

Musella, Alessandra

Mandolesi, Georgia

De Vito, Francesca

Furlan, Roberto

Finardi, Annamaria

Marfia, Girolama A.

Centonze, Diego https://orcid.org/0000-0002-8390-8545
Buttari, Fabio
License Information

Text and Data Mining valid from 2018-08-28
More Information

Article History

Received: 22 May 2018

Revised: 30 July 2018

Accepted: 31 July 2018

First Online: 28 August 2018

Compliance with ethical standards

:

: On behalf of all authors, the corresponding author states that there is no conflict of interest.